BIO-CAT strives to make a meaningful difference through new technology and research. Over the past 30 years BIO-CAT has composed 14 patents and has three patents pending. BIO-CAT’s IP is inclusive of human therapeutics, ingredient processing and probiotic use.
Through our years of research, BIO-CAT has been published in multiple peer reviewed journals and continues publishing in prolific top journals today.
Brutscher LM, Borgmeier C, Garvey SM, Spears JL. Preclinical Safety Assessment of Bacillus subtilis BS50 for Probiotic and Food Applications. Microorganisms. 2022;10(5):1038. https://doi.org/10.3390/microorganisms10051038
Garvey SM, Guice JL, Hollins MD, et al. Fungal Digestive Enzymes Promote Macronutrient Hydrolysis in the INFOGEST Static In Vitro Simulation of Digestion. Food Chemistry. 2022;386:132777. https://doi.org/10.1016/j.foodchem.2022.132777
Spears JL, Kramer R, Nikiforov AI, et al. Safety Assessment of Bacillus subtilis MB40 for Use in Foods and Dietary Supplements. Nutrients. 2021;13(3). https://doi.org/10.3390/nu13030733
Penet C, Kramer R, Little R, et al. A Randomized, Double-Blind, Placebo-Controlled, Parallel Study Evaluating the Efficacy of Bacillus subtilis MB40 to Reduce Abdominal Discomfort, Gas, and Bloating. Alternative Therapies in Health and Medicine. 2019;25(12). http://alternative-therapies.com/oa/6199.html.
BIO-CAT holds multiple patents in the fields of probiotic applications, enzyme therapeutics, and enzyme processing.
Learn about enzymes, probiotics and microbials in our resource library.
We’re as passionate as you are about scientific innovation that matters
Learn More
© 2023 www.bio-cat.com.
